
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, a... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 49.0187 | 6.37227169321 | 769.25 | 820.7178 | 765.2 | 2889701 | 797.68356075 | CS |
4 | 78.2687 | 10.5768513514 | 740 | 820.7178 | 709 | 3492092 | 752.29670105 | CS |
12 | -19.0213 | -2.27176963776 | 837.29 | 902.4999 | 677.0912 | 4093173 | 777.4599514 | CS |
26 | 38.2687 | 4.90624358974 | 780 | 935.625 | 677.0912 | 3863354 | 798.26576058 | CS |
52 | -50.4113 | -5.80320716489 | 868.68 | 972.53 | 677.0912 | 3638129 | 826.61837572 | CS |
156 | 527.5737 | 181.487022481 | 290.695 | 972.53 | 283.11 | 3195955 | 617.50368748 | CS |
260 | 676.2687 | 476.24556338 | 142 | 972.53 | 129.21 | 3250877 | 450.20618165 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions